0

Global Pneumonia Therapeutics Market 2017-2021

  • Published: Nov 2017
  • Pages: 87
  • SKU: IRTNTR15799
Technavio

Enjoy complimentary customisation on priority with our Enterprise License!

Get me the latest version! (includes COVID-19 impact)
Safe and Secure SSL Encrypted

info
close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

2500 USD

This industry research report identifies GlaxoSmithKline, Merck Sharp & Dohme, Novartis, and Pfizer as the key vendors in the global pneumonia therapeutics market. This industry research report also presents a detailed analysis of the market by product type (vaccines, anti-infectives, and oxygen therapy), by pneumonia type (CAP and HCAP), and by geography (the Americas, APAC, and EMEA).

Overview of the global pneumonia therapeutics market

The emergence of advanced diagnostic techniques such as the use of biomarkers for diagnosing pneumonia has improved the identification rate of respiratory infections. The molecular diagnostic technique aids in understanding the outbreak and transmission of disease. Technavio’s market research study has identified the emergence of advanced diagnostic techniques to be one of the primary factors fueling the growth of the pneumonia therapeutics market in the coming years. The emergence of advanced diagnosis provides various benefits such as improved organism quantification, differentiation, and typing and profiling of antibiotic resistance. With the growing need for early and precise diagnosis there is an increasing demand for drugs to treat pneumonia, which in turn, fuels market growth. Our market research analysts have estimated that this market will grow steadily at a CAGR of almost 7% by 2021.

There is an increasing prevalence of respiratory tract infections such as community-acquired pneumonia (CAP) and ventilator-associated pneumonia (VAP). CAP is one of the major causes of mortality and morbidity and the increase in such cases is mainly due to the rising concerns about antibiotic resistance. This induces the need for clinical studies for the treatment of CAP and VAP, which further contributes to the demand for pneumonia therapeutic drugs. According to our analysts, the rise in respiratory infection cases will be one of the key trends a that will have a positive impact on the pneumonia therapeutics market in the coming years.

Competitive landscape and key vendors

The pneumonia therapeutics market is moderately fragmented owing to the presence of several international, regional, and local vendors. Key vendors in this pneumonia treatment market are investing heavily in R&D to innovate novel drugs. To strengthen their market positions, the players in the pneumonia therapeutics market are following strategic activities such as M&A.

The leading vendors in the market are

  • GlaxoSmithKline
  • Merck Sharp & Dohme
  • Novartis
  • Pfizer

The other vendors in the market are AstraZeneca, Bayer, Biotest, Ono Pharmaceutical, and Tetraphase Pharmaceuticals.

Segmentation by product type and analysis of the pneumonia therapeutics market

  • Vaccines
  • Anti-Infectives
  • Oxygen Therapy

The vaccine segment accounts for major share of the pneumonia treatment market due to its high efficiency in the prophylaxis of pneumonia and its cost-effectiveness. The high annual cost for drug therapy and the increased awareness and need for the prevention of pneumonia, will contribute to the growth of the pneumonia therapeutics market in this segment.

Geographical segmentation and analysis of the pneumonia therapeutics market

  • Americas
  • APAC
  • EMEA

The Americas will be the major revenue contributor to the pneumonia therapeutics market due to the availability of an excellent infrastructure and the presence of developed economies. This region consists of several major key players that are actively engaged in launching new and innovative products. Additionally, the increasing health awareness and the initiatives taken for the prevention of pneumonia will further contribute to the growth of the pneumonia treatment market in this region.

Key questions answered in the report include

  • What will the market size and the growth rate be in 2021?
  • What are the key factors driving the global pneumonia therapeutics market?
  • What are the key market trends impacting the growth of the global pneumonia therapeutics market?
  • What are the challenges to market growth?
  • Who are the key vendors in the global pneumonia therapeutics market?
  • What are the market opportunities and threats faced by the vendors in the global pneumonia therapeutics market?
  • Trending factors influencing the market shares of the Americas, APAC, and EMEA.
  • What are the key outcomes of the five forces analysis of the global pneumonia therapeutics market?

Technavio also offers customization on reports based on specific client requirement.

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: INTRODUCTION

  • Market outline

PART 05: DISEASE OVERVIEW

PART 06: MARKET ECOSYSTEM

  • Market segmentation analysis

PART 07: MARKET SIZING

  • Market size and forecast 2016-2021

PART 08: PIPELINE ANALYSIS

PART 09: FIVE FORCES ANALYSIS

PART 10: MARKET SEGMENTATION BY PRODUCT TYPE

  • Segmentation by product type
  • Comparison by product type
  • Global pneumonia vaccines market
  • Global pneumonia anti-infectives market
  • Global pneumonia oxygen therapy market
  • Market opportunity by product type

PART 11: MARKET SEGMENTATION BY PNEUMONIA TYPE

  • CAP
  • HCAP

PART 12: REGIONAL LANDSCAPE

  • Geographical segmentation
  • Regional comparison
  • Pneumonia therapeutics market in Americas
  • Pneumonia therapeutics market in EMEA
  • Pneumonia therapeutics market in APAC
  • Market opportunity

PART 13: DECISION FRAMEWORK

PART 14: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 15: MARKET TRENDS

  • Strong pipeline
  • Rising global initiatives for pneumonia treatment
  • Rise in respiratory infection cases

PART 16: VENDOR LANDSCAPE

PART 17: VENDOR ANALYSIS

  • Vendor overview
  • GlaxoSmithKline
  • Merck Sharp & Dohme
  • Novartis
  • Pfizer

PART 18: APPENDIX

  • List of abbreviations

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

TechnavioINFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases
Technavio

TechnavioDATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts
Technavio

TechnavioREPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape
Interested in this report?
Get your sample now!
  • What are the key global market and the regional market share?
  • What are the revenue-generating key market segments?
  • What are the key factors driving and challenging this market’s growth?
  • Who are the key market vendors and their growth strategies?
  • What are the latest trends influencing the growth of this market?
  • What are the variables influencing the market growth in the primary regions?
  • What are the factors influencing the growth of the parent market?
  • Off-the-shelf research reports
  • Reports can be tailored to meet the customer's needs
  • Trusted by more than 100 fortune 500 organizations
  • Information about the market's key drivers, trends, and challenges
  • Parent market analysis
  • Every week, 50,000 people visit our subscription platform
  • Detailed vendors report with competitive landscape
  • Covid-19 impact and recovery analysis
  • Data on revenue-generating market segments
  • Details on the market shares of various regions
  • Five-force market analysis

Certified ISO 9001 : 2015

We are ISO recognized

We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

We are GDPR and CCPA compliant

We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

Safe and Secure SSL Encrypted
Technavio

info
close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

2500 USD

Technavio Get the report (PDF) sent to your email within minutes.

Subscribe & Save

Get lifetime access to our
Technavio Insights

Customized Report as per your Business Needs

  • Our analysts will work directly with you and understand your needs
  • Get data on specified regions or segments, competitor and Vendors
  • Data will be formatted and presented as per your requirements
  • We offer $1000 worth of FREE customization at the time of purchase

Let us help you make report more suited to your requirements.

  • Get a competitive breakdown as per your niche industry
  • Customize the data with various metrics that meet your business prerequisite
  • Understand Revenue Sources, Customers and many more
  • Details on Market Share
  • These customizations are done in a short amount of time by our analysts and industry experts
Technavio
Enquire Before Buying
17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>